Best Medical Stocks To Buy Right Now

What’s the next big thing? If you’ve been following us at Money Morning, you know it’s medical and legal marijuana.

In 2018, the market for legal weed and medical marijuana is going to explode.

According to Grandview Research, the global medical marijuana market should reach a value of $55.8 billion by 2025. That’s thanks to rising awareness regarding medical applications such as pain management, appetite enhancement, and reducing eye pressure.

In fact, Wiseguyreports.com says that the medical marijuana market will grow at a compound annual growth rate of more than 21% by 2022.

Best Medical Stocks To Buy Right Now: Calavo Growers, Inc.(CVGW)

Advisors’ Opinion:

  • [By Peter Graham]

    Small cap avocado and fresh food stock Calavo Growers (NASDAQ: CVGW) has elevated short interest of 33.51% according to Highshortinterest.com. Founded in 1924, Calavo Growers is a global avocado-industry leader and an expanding provider of value-added fresh food serving retail grocery, foodservice, club stores, mass merchandisers, food distributors and wholesalers worldwide. The Companys Fresh segment procures and markets fresh avocados and select other fresh produce (tomatoes) while the Renaissance Food Group segment (RFG) creates, markets and distributes a portfolio of healthy, fresh foods, including fresh-cut fruit, fresh-cut vegetables and prepared foods. The Foods segment manufactures and distributes guacamole and salsa. Fresh food products are sold under the respected Calavo brand name as well as Garden Highway, Chef Essentials and a variety of private label and store brands.

Best Medical Stocks To Buy Right Now: NRG Energy Inc.(NRG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    DTE Energy (NYSE: DTE) and NRG Energy (NYSE:NRG) are both utilities companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, institutional ownership, profitability, valuation, risk, dividends and analyst recommendations.

Best Medical Stocks To Buy Right Now: Globus Medical, Inc.(GMED)

Advisors’ Opinion:

  • [By Logan Wallace]

    Globus Medical Inc (NYSE:GMED) – Research analysts at William Blair cut their Q2 2018 earnings per share (EPS) estimates for shares of Globus Medical in a report released on Thursday, May 3rd. William Blair analyst K. Krum now forecasts that the medical device company will earn $0.35 per share for the quarter, down from their previous estimate of $0.37. William Blair also issued estimates for Globus Medical’s Q3 2018 earnings at $0.35 EPS, FY2018 earnings at $1.52 EPS, Q1 2019 earnings at $0.42 EPS, Q3 2019 earnings at $0.42 EPS, Q4 2019 earnings at $0.46 EPS and FY2019 earnings at $1.71 EPS.

Best Medical Stocks To Buy Right Now: Sherwin-Williams Company (SHW)

Advisors’ Opinion:

  • [By Lisa Levin] Companies Reporting Before The Bell
    United Technologies Corporation (NYSE: UTX) is estimated to report quarterly earnings at $1.51 per share on revenue of $14.62 billion.
    The Coca-Cola Company (NYSE: KO) is expected to report quarterly earnings at $0.46 per share on revenue of $7.31 billion.
    Caterpillar Inc. (NYSE: CAT) is projected to report quarterly earnings at $2.07 per share on revenue of $11.93 billion.
    Verizon Communications Inc. (NYSE: VZ) is expected to report quarterly earnings at $1.11 per share on revenue of $31.22 billion.
    Lockheed Martin Corporation (NYSE: LMT) is estimated to report quarterly earnings at $3.42 per share on revenue of $11.28 billion.
    The Sherwin-Williams Company (NYSE: SHW) is projected to report quarterly earnings at $3.15 per share on revenue of $3.94 billion.
    Biogen Inc. (NASDAQ: BIIB) is expected to report quarterly earnings at $5.92 per share on revenue of $3.15 billion.
    3M Company (NYSE: MMM) is estimated to report quarterly earnings at $2.52 per share on revenue of $8.26 billion.
    JetBlue Airways Corporation (NASDAQ: JBLU) is projected to report quarterly earnings at $0.2 per share on revenue of $1.75 billion.
    Eli Lilly and Company (NYSE: LLY) is expected to report quarterly earnings at $1.13 per share on revenue of $5.49 billion.
    Harley-Davidson, Inc. (NYSE: HOG) is estimated to report quarterly earnings at $0.88 per share on revenue of $1.25 billion.
    Corning Incorporated (NYSE: GLW) is expected to report quarterly earnings at $0.3 per share on revenue of $2.50 billion.
    Centene Corporation (NYSE: CNC) is projected to report quarterly earnings at $1.88 per share on revenue of $13.28 billion.
    The Travelers Companies, Inc. (NYSE: TRV) is estimated to report quarterly earnings at $2.77 per share on revenue of $6.75 billion.
    Wipro Limited (NYSE: WIT) is expected to report quarterly earnings at $0.07 per share on revenue of $2.16 billion.
    PACCAR Inc (NASDAQ: PCAR) is projected to
  • [By Max Byerly]

    Burney Co. decreased its position in Sherwin-Williams (NYSE:SHW) by 2.5% in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 9,064 shares of the specialty chemicals company’s stock after selling 233 shares during the period. Burney Co.’s holdings in Sherwin-Williams were worth $3,554,000 as of its most recent filing with the SEC.

  • [By Dan Caplinger]

    Major corporate acquisitions are complicated to work through, and often, surprises come up that prove more costly than anticipated. Paint and coatings manufacturer Sherwin-Williams (NYSE:SHW) has worked long and hard to close on its acquisition of Valspar last year, but even now, there’s work left to do to integrate the two businesses fully to take maximum advantage of their potential synergies.

  • [By Dan Caplinger]

    Investors like dividend stocks that aren’t stingy with their payouts. Yet even among the elite ranks of the Dividend Aristocrats — stocks that have increased their annual payments to shareholders for at least 25 straight years — you can find some companies with dividend yields that are embarrassingly low. Below, we’ll look more closely at Roper Technologies (NYSE:ROP), S&P Global (NYSE:SPGI), and Sherwin-Williams (NYSE:SHW) to see why they give investors a somewhat mixed picture when it comes to dividends.

  • [By Motley Fool Staff]

    Sherwin-Williams (NYSE:SHW) Q1 2018 Earnings Conference CallApril 24, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

Best Medical Stocks To Buy Right Now: Intercept Pharmaceuticals, Inc.(ICPT)

Advisors’ Opinion:

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

Leave a Reply

Your email address will not be published. Required fields are marked *